Skip to main content
FinSpry Logo
FinSpry
TXG logo
TXG
(NASDAQ)
10x Genomics, Inc.
$29.05-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

10x Genomics (TXG) Stock Price & Financial Analysis

10x Genomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.01 - $29.62
52-Week High$35.65
52-Week Low$10.17
Open$29.34
Volume2.95M
Average Volume (3M)3.02M
Market Cap3.63B
Shares Outstanding124.75M
Price to Sales (P/S)5.65
Price to Book (P/B)4.56
EV/EBITDA-180.62
Revenue (TTM)642.82M
Net Income (TTM)-43.54M
Free Cash Flow (TTM)130.12M
EPS (TTM)$-0.35
Profit Margin-6.77%
Operating Margin-9.49%
Return on Equity (ROE)-5.47%
Debt to Equity0.20
50-Day MA$24.35
200-Day MA$18.65
52-Week Change169.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About 10x Genomics

What is the current stock price for TXG?

As of the latest trading session, TXG stock trades at $29.05. The 52-week range is $10.17–$35.65, with a day range of $28.01–$29.62.

What is the P/E ratio for TXG?

The P/E ratio (Price-to-Earnings) for TXG is shown in the Key Statistics section. This valuation metric helps compare 10x Genomics, Inc. to industry peers.

Does TXG pay dividends?

10x Genomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TXG?

Based on 5 analysts, the consensus for TXG is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TXG?

10x Genomics's market capitalization is $3.62B, classifying it as a mid-cap company..